Industry

Galderma, the pure-play dermatology category leader with a 40+ year heritage in dermatology, will present one oral, six symposia and four hub sessions demonstrating its scientific expertise and ongoing commitment to advancing dermatology 18 scientific and clinical posters will unveil new data on skin disease awareness and scientific innovation in prurigo nodularis, sensitive skin, acne, … [Read more…]

BEIJING–(BUSINESS WIRE)–InnoCare Pharma (HKEX: 09969), a leading biopharmaceutical company for the treatment of cancer and autoimmune diseases, announced today that BTK inhibitor orelabrutinib has been granted priority review for the treatment of relapsed or refractory Marginal Zone Lymphoma (R/R MZL) by the Center for Drug Evaluation (CDE) of the China National Medical Products Administration (NMPA), … [Read more…]

Presentation of a new multi-biomarker panel with 95% accuracy for stage 1 to 3 ovarian cancer based on targeted mass spectrometry (MS) and bioinformatics Research results through Bertis’ technology platform were published as a cover article in the September issue of the international scientific journal, ‘Journal of Proteome Research’ SEONGNAM, South Korea–(BUSINESS WIRE)–#Bertis—Bertis, a proteomics-based … [Read more…]

MONTPELLIER, France–(BUSINESS WIRE)–The approval obtained by the EIB is for a new credit facility of 40 million euros The new credit facility foresees that MedinCell repays in anticipation a previous 20 million euros loan signed in 2018 with the EIB 30 million euros of the credit facility could be drawn in Q4 2022, and the … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “External Remote Patient Monitoring Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update” report has been added to ResearchAndMarkets.com’s offering. The report provides comprehensive information about the External Remote Patient Monitoring Devices pipeline products with comparative analysis of the products at various stages of … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “US Dry Eye Market and Competitive Landscape – 2022” report has been added to ResearchAndMarkets.com’s offering. US Dry Eye Market and Competitive Landscape Report provides comprehensive insights into Dry Eye pipeline products, Dry Eye epidemiology, Dry Eye market valuations and forecast, Dry Eye drugs sales and competitive landscape in the US. The research … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “US Smoking Cessation Market and Competitive Landscape – 2022” report has been added to ResearchAndMarkets.com’s offering. US Smoking Cessation Market and Competitive Landscape report provides comprehensive insights into Smoking Cessation pipeline products, Smoking Cessation epidemiology, Smoking Cessation market valuations and forecast, Smoking Cessation drugs sales and competitive landscape in the US. The research … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “US Migraine Market and Competitive Landscape – 2022” report has been added to ResearchAndMarkets.com’s offering. US Migraine Market Report provides comprehensive insights into Migraine pipeline products, Migraine epidemiology, Migraine market valuations and forecast, Migraine drugs sales and competitive landscape in the US. The research is classified into seven sections – Migraine treatment options, … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “US Opioid Addiction Market and Competitive Landscape – 2022” report has been added to ResearchAndMarkets.com’s offering. US Opioid Addiction Market Report provides comprehensive insights into Opioid Addiction pipeline products, Opioid Addiction epidemiology, Opioid Addiction market valuations and forecast, Opioid Addiction drugs sales and competitive landscape in the US. The research is classified into … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “US Hepatitis B Market and Competitive Landscape – 2022” report has been added to ResearchAndMarkets.com’s offering. US Hepatitis B Market report provides comprehensive insights into Hepatitis B pipeline products, Hepatitis B epidemiology, Hepatitis B market valuations and forecast, Hepatitis B drugs sales and competitive landscape in the US. The research is classified into … [Read more…]